<- Go Home
Panacea Acquisition Corp.
As of February 10, 2021, Panacea Acquisition Corp. was acquired by Nuvation Bio Inc., in a reverse merger transaction. Panacea Acquisition Corp., a blank check company, focuses on effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or similar business combination with one or more businesses. The company was founded in 2020 and is based in San Francisco, California.
Market Cap
$180.4M
Volume
109.7K
Cash and Equivalents
$908.1K
EBITDA
N/A
Tax Rate Collected
N/A
Tax Rate Ratio
N/A
Gross Profit
N/A
Profit Margin
N/A
52 Week High
$12.52
52 Week Low
$9.25
Dividend
N/A
Price / Book Value
37.02
Price / Earnings
N/A
Price / Tangible Book Value
37.02
Enterprise Value
N/A
Enterprise Value / EBITDA
N/A
Operating Income
-$4.6M
Return on Equity
N/A
Return on Assets
N/A
Cash and Short Term Investments
$908.1K
Debt
N/A
Equity
$5.0M
Revenue
N/A
Unlevered FCF
N/A
Sector
Capital Markets
Category
N/A